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SUMMARY 
A cladistic analysis was carried out to identify haplotypes hypothesized to differ for 
functional DNA sequence variations within the apolipoprotein (apo) AI-CIII-AIV gene cluster 
that affect plasma lipid, lipoprotein and apolipoprotein levels. A sample of unrelated healthy 
French Canadians was studied. First, a cladogram of the observed apo AI-CIII-AIV haplotypes 
was estimated. Then this cladogram was used to define a statistical analysis of the association 
between haplotype variation and variation in plasma lipid, lipoprotein and apolipoprotein 
levels. Three haplotypes were identified which were associated with small (5-12% of the total 
sum of squares) pleiotropic effects on plasma lipid, lipoprotein and apolipoprotein traits and 
these effects were context, i.e. gender, dependent. 
INTRODUCTION 
One of the objectives of human quantitative genetics is to characterize the DNA sequence 
variations that influence interindividual phenotypic differences in traits that  are continuously 
distributed in the population a t  large. The first step in accomplishing this is to identify 
haplotypes which differ for these functional sequence variations. This study is aimed at  
identifying such haplotypes associated with interindividual variation in quantitative traits 
known to contribute to  the risk of developing coronary artery disease (CAI)). We present here 
a cladistic analysis (Templeton et al. 1987, 1988, 1992; Sing et al. 1992; Haviland, 1993; 
Templeton & Sing, 1993) to  identify haplotypes hypothesized to have DNA sequence 
differences, within the apolipoprotein (apo) AI-CIII-AIV gene cluster, which have relatively 
small effects on plasma lipid, lipoprotein and apolipoprotein levels. 
We begin with a justification for the use of a cladistic analysis for identifying haplotypes that 
differ for functional interindividual DNA sequence variations in a gene hypothesized to  be 
involved in the genetic architecture of a quantitative trait. Genetic architecture is defined by 
the number of genes involved in the metabolism of the trait, the number of alleles at each gene 
and their relative frequencies, the arrangement of these alleles into genotypes, the impact of 
each of the alleles, single locus genotypes and multilocus genotypes on intra- and interindividual 
trait variation and the impact of each of these alleles and genotypes on the relationships 
between the trait and other traits (Boerwinkle et al. 1986; Sing et al. 1992a, b) .  There are two 
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general approaches taken when studying the genetic architecture of continuously distributed 
risk factor traits: the top-down and the bottom-up approaches (reviewed by Sing et al. 1985, 
1988; Sing & Moll, 1990). 
The top-down approach involves estimating the impact of the effects of unmeasured genetic 
and environmental factors on trait variation among individuals in the population at large using 
genealogical relationships (biometrical top-down approach) or characterizing the genotypes 
associated with specific trait values (molecular top-down approach). The biometrical top-down 
approach estimates the genetic component of trait variation but cannot be used to address 
questions about the location of functional sequence variations (reviewed by MacCluer, 1992 ; 
Moll, 1993). The molecular top-down approach involves selecting individuals a t  the tails of the 
trait distribution, e.g. individuals with very high and very low plasma cholesterol levels, with 
the ultimate aim of comparing their DNA sequences to determine sequence differences that may 
be responsible for the extreme phenotypes. The molecular top-down approach has been 
successful in identifying rare mutations with large effects (e.g. Goldstein & Brown, 1989), but 
has contributed little to our understanding of the genetic architecture of a quantitative trait in 
the population at large. The molecular top-down approach, which uses samples of individuals 
from the tails of a trait distribution, gives no information about the penetrance functions (i.e. 
distribution of phenotypes in the population at large) associated with each of the many 
functional interindividual DNA sequence variations that are involved in the genetic 
architecture of a trait (see for example, Hobbs et al. 1989; Roy et al. in press). Also, 
identifying the specific DNA sequence variations with a functional effect is not a trivial problem 
(e.g. Choudhary & Laurie, 1991; Laurie et al. 1991) because there are certain to be many 
nucleotide differences between sequences which are not functionally involved in the 
determination of phenotypic differences (Ohno, 1972 ; Kimura, 1983 ; Zuckerkandl, 1992). A 
method to reduce the number of nucleotide differences to those most likely to be responsible for 
a phenotypic difference is needed. 
The bottom-up approach involves measuring genetic variation (e.g. RFLP markers or DNA 
sequences) and studying its association with phenotypic variation in samples representative of 
the frequency distribution of the trait in a particular population of inference (reviewed by 
Cooper & Clayton, 1988; Lusis, 1988; Fisher et al. 1989). Haplotypes that associate with 
significantly different trait levels would then be candidates for sequence comparison studies to 
find the functional interindividual DNA sequence variation(s). Unfortunately, results from 
published single locus genotype-phenotype association studies have been largely inconclusive 
due to the inconsistency of results among the samples studied (Cooper & Clayton, 1988). 
Inconsistent findings may be a consequence of an unrepresentative sampling criterion or small 
sample sizes inflating type I and I1 errors respectively. Furthermore, even if samples are large 
and representative of the populations of interest, the populations from which the samples were 
drawn may be genetically different. For example, the functional interindividual DNA sequence 
variation may be present in some and not other populations, the linkage disequilibria 
relationships between marker loci and functional interindividual DNA sequence variations may 
differ among populations, and/or the frequencies of alleles at other genetic loci, involved in gene 
by gene interactions with the functional interindividual DNA sequence variations, may differ 
among populations (Bodmer & Thomson, 1977; Cooper & Clayton, 1988; Schull & Hanis, 1990; 
Haviland et al. 1991 ; Zerba & Sing, 1993). Although single locus genotype-phenotype 
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association studies have proved useful in confirming the involvement of candidate genes in the 
determination of CAD risk factor trait levels (Kessling et al. 1992), the inferences that can be 
drawn from these studies about genetic architecture are limited. 
Since RFLP sites are common in the genome, many investigators type more than one RFLP 
in a region and carry out a series of single RFLP-phenotype association studies. RFLP- 
phenotype association studies that compare results of multiple single RFLP analyses to decide 
which RFLP is closest to the functional interindividual DNA sequence variation are 
inappropriate for two reasons. First, this approach inappropriately assumes that the RFLP 
sites are statistically independent, i.e. the RFLP sites are in linkage equilibria. Secondly, in 
short regions, there is a lack of correlation between the level of disequilibrium and the distance 
between loci (e.g. Litt & Jorde, 1986; Borresen et al. 1988; Hegele et al. 1990; Haviland et al. 
1991 ; Zerba et al. 1991), so results from multiple single RFLP-phenotype association studies 
cannot be compared to localize the functional interindividual DNA sequence variations. 
Rather than do a series of single RFLP-phenotype association studies, multiple RFLP 
haplotypes have been constructed for genotype-phenotype association studies (e.g. Aquadro et 
al. 1992). But, as the number of markers increases and the number of individuals in each 
genotype class decreases, the statistical power to detect significant phenotypic differences 
among haplotypes decreases. This decreased statistical power becomes critical in the study of 
quantitative traits because it is expected that the majority of the effects contributing to the 
genetic architecture of a quantitative trait will be small (Tanksley, 1993; Haviland et al. 
submitted). Also, because each individual has a unique genomic sequence, there is the potential 
for the number of possible haplotypes to  be greater than the number of individuals in the 
sample or even in the population being studied. Even with modest numbers of RFLP markers, 
the number of pairwise comparisons among haplotypes needed to identify which haplotypes are 
associated with significant phenotypic differences may exceed the number of available degrees 
of freedom (Templeton et al. 1987). To solve these problems, Templeton et al. developed the 
theory for a cladistic analysis of the association between haplotype variation and phenotype 
variation (Templeton et al. 1987, 1988, 1992; Sing et al. 1992; Haviland, 1993; Templeton & 
Sing, 1993). This approach uses the available degrees of freedom to test only those contrasts 
that have the highest probability of calling attention to  haplotypes that differ for functional 
interindividual sequence variation(s). 
A cladistic analysis of the apo AI-CIII-AIV gene cluster will be described here. The 
apolipoproteins, apo AI ,  apo CIII and apo AIL’, are known to be involved in lipoprotein 
metabolism and many genotype-phenotype association studies have established that variations 
in the genes coding for these apolipoproteins are associated with interindividual variation in 
plasma lipid, lipoprotein and apolipoprotein traits (reviewed by Breslow, 1988 ; Humphries, 
1988; Lusis, 1988; Boerwinkle & Hixson, 1990; Chan et al. 1990; Kessling et al. 1992). But, little 
progress has been made in the identification of candidate DNA sequences responsible for the 
impact of these genes on plasma lipid, lipoprotein and apolipoprotein levels and ultimately the 
progression of disease (Karathanasis et al. 1983, 1987; Pagani et al. 1989; Smith et al. 1992; 
Tuteja et al. 1992; Von Eckardstein et al. 1992). In this paper, we report the identification of 
three apo AI-CIII-AIV haplotypes hypothesized to carry functional DNA sequence variations 
with small pleiotropic effects on plasma lipid, lipoprotein and apolipoprotein levels that are 
gender dependent. 
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Fig. 1 .  Diagram of apo AI-CIII-AIV region on rhromosome 1 1  depicting locations of apolipoprotein 
genes and six RFLP loci. The arrows below the genes denote the direction of transcnription. 
METHODS 
Cladistic analysis 
The cladistic analysis has been described fully elsewhere (Templeton et al. 1987, 1988, 1992; 
Sing et al. 1992; Haviland, 1993; Templeton & Sing, 1993) and is only briefly summarized here. 
Two steps are involved. In the first step an unrooted cladogram, i.e. network, is built by 
organizing the haplotypes such that the mutational steps, hypothesized to reflect the 
evolutionary history that produced the current array of haplotypes, are displayed. The method 
of maximum parsimony was used to estimate the cladogram (Felsenstein, 1983; Sober, 1983; 
Stewart, 1993). The gene cladogram is then used to define a statistical design with which to 
analyse the association between haplotype variation and phenotype variation. 
In the second step, instead of executing an analysis which considers all possible pairwise 
comparisons between haplotypes, a nested testing scheme is defined by the cladogram 
structure. The nesting starts by defining each unique haplotype as a O-step clade, where step 
refers to single mutational changes that result in the gain or loss of a restriction cut site or the 
creation of the insertion/deletion polymorphism. One-step clades are defined by starting at 
terminal haplotypes (i.e. ones that are connected to  only one other haplotype) and moving in 
one step. Two-step, and higher, clades are defined analogously. The phenotypic values of a trait 
are then compared among individuals who are grouped according to haplotype relationships 
defined by the cladogram. Haplotypes that have few RFLP differences, i.e. are near each other 
in the cladogram, but are associated with statistically significant phenotypic differences, are 
those hypothesized to differ for functional DNA sequence variations. The functional DNA 
sequence variations will most likely not be the RFLP markers used to define the haplotypes. 
Sample, lipid, lipoprotein and apolipoprotein determination and RFLP typing 
The sample consisted of 167 individuals of French Canadian (FC) ancestry drawn from a 
larger sample of healthy unrelated white-collar workers at Hydro-Quebec, a utility company in 
Montreal, Canada. This larger sample has been described elsewhere (Haviland P t  al. 1991 ; 
Xhignesse et al. 1991 ; Zerba et al. 1991 ; Kessling et al. 1992). The a priori exclusion criteria used 
to define the healthy sample were: age below 20 or above 59 years, known hypertension, 
diabetes, glucose intolerance, hyperlipidemia, gross obesity (body mass index > 30 kg/m2), non- 
fasting state, or the taking of regular, or recent, prescription or non-prescription medication 
(except women taking contraceptive or replacement hormones). An a posteriori exclusion 
procedure was also used, including the following criteria : hyperuricemia, hyperglycemia. 
abnormal liver function tests, urea or electrolytes, non-FC ancestry, missing results, known 
Cladistic analysis of apo AI-CIII-AIV 215 
kinship with others in the sample, or lipid, lipoprotein or apolipoprotein levels greater than 4 
S.D.  from the sample mean. To determine ancestry, the sampled individuals were asked whether 
they knew of any ancestor of theirs who was not FC and to list the surnames and maiden names 
of their grandparents. 167 individuals were successfully typed for six RFLP loci in the apo AI- 
CIII-AIV gene cluster. This sample has five fewer individuals than the one described in 
Haviland et al. (1991) because one individual was removed due to missing plasma lipoprotein 
data and four individuals were removed during a subsequent verification of the RFLP typings 
(see below). 
Plasma levels of total cholesterol, LDL-C, apo B, VLDL-C, apo AI, HDL-C, triglycerides and 
lipoprotein (a) (Lp(a)) were determined as described elsewhere (Xhignesse et al. 1991 ; Kessling 
et al. 1992). DNA extraction, digestion, blotting, hybridization, and autoradiography have also 
been described elsewhere (Kessling et al. 1992). Two probes were used. Taken 5' to 3', they were 
a 2.2 kb PstI genomic fragment (Kessling et al. 1985), which was used to detect the XmnI 
(Kessling et al. 1985; Coleman et al. 1986; Kessling et al. 1988b), TaqI (Cohen et al. 1986), PstI 
(Kessling et al. 1985) and SstI RFLP loci (Rees et al. 1983), and 1.05 kb (Kessling et al. 1988c), 
a genomic probe which was used to detect the PvuII RFLP (Oettgen et al. 1986). Fig. 1 depicts 
the location of the six RFLP sites in relation to  the apolipoprotein genes. In  this paper, 0 and 
1 denote uncut and cut RFLP alleles (insert and no insert) respectively. 
The RFLP data used in this paper were collected and checked in a multistage process. At the 
time that the RFLP loci were originally typed, data exclusion occurred when three investigators 
independently reading the autoradiographs did not agree on the typing of an individual's 
genotype. Typings were repeated when DNA was present in sufficient amounts. At a latter 
stage, RFLP typings were checked again in four individuals who carried a rare haplotype (seen 
only once in the sample) and 24 individuals for whom haplotypes could not be determined 
unambiguously because they were heterozygous at  two or more RFLP sites. The SstI and PstI  
RFLP loci were retyped using a PCR based assay (A. Minnich, personal communication), and 
the other RFLP loci were checked by re-reading the blots from the original analyses. Due to 
this data verification, four individuals were removed from the analysis because the original 
typings could not be confirmed. 
The genotype frequencies based on the 147 individuals for whom haplotypes could be 
determined unambiguously (i.e. they were heterozygous a t  no more than one RFLP site) are 
given in Table 1. As shown in the Table, the majority of the sample for whom haplotypes could 
be unambiguously determined carried at  least one copy of a specific haplotype designated 
haplotype 6. The cladistic analysis of the apo AI-CIII-AIV gene cluster presented in this paper 
includes only those individuals for whom haplotypes could be determined unambiguously and 
who carried a t  least one copy of haplotype 6 (n  = 140). In other words, only one allele for the 
apo AI-CIII-AIV gene cluster varied among individuals, the other allele was invariant. Thus, 
the genotypes could be analysed as if they were haploid and a parametric statistical test could 
be used to test for differences among individuals grouped according to haplotype relationships 
(Haviland, 1993). 
Statistical analysis 
All analyses were done using the SAS statistical package (SAS Institute Inc. 1989). To guard 
against type I1 errors, which were likely given that the size of the association between 
haplotype and trait variation was expected to be small, statistical tests that  gave p-values 
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Table 1 .  Genotype frequencies 
Haplotype 11 
1 2  3 4 5 6 7 8 9 10 
1 0 0 0 0 0 20 0 0 0 0 
2 0 0 1 0 0 0 0 0 0 0  
3 0 0 0 0 0 5 0 0 0 0  
4 0 0 0 0 0 0 0 1 0 0  
5 0 0 0 0 0 9 0 0 0 0  
6 0 0 0 0 0 74 0 0 0 0 
7 0 0 0 0 0 I2 0 0 0 0 
8 0 0 0 0 0 14 0 2 0 0 
9 0 0 1 0 0 0 0 0 0 0  
10 0 0 0 0 0 6 0 0 0 2  
Total 0 0 2 0 0 1 4 0 0  3 0 2 
Haplotype I 
equal to  or less than 010 were considered significant. The results of the statistical tests are 
reported using two significance levels, marginally significant 005 d p < 0.10 and significant 
p d 005. All analyses were done separately in females and males. Those traits, VLDL-C, 
triglycerides and Lp(a), that were not normally distributed (results not shown) were 
transformed with the natural logarithm to reduce skewness. The means and variances for the 
concomitants and plasma lipid, lipoprotein and apolipoprotein traits were estimated. 
Homogeneity of variance between the genders was tested using the F-test and the means were 
tested for homogeneity using the t-test (Sokal & Rohlf, 1981). Satterthwaite’s t-test correction 
was used if the variances were significantly heterogeneous between the genders. 
The plasma lipid, lipoprotein and apolipoprotein levels were adjusted separately in females 
and males by multiple polynomial regression for the concomitants : age, height, and weight to 
the third power, smoking and, in females, hormone use (Neter et al. 1985). The residuals were 
used in a one-way analysis of variance. Then single degree of freedom contrasts, defined by the 
cladogram, were made to detect statistically significant associations between haplotype 
variation and variation in adjusted plasma lipid, lipoprotein and apolipoprotein levels. Tests of 
the assumption of homogeneity of variance between the pairs of haplotypes contrasted in the 
analysis of variance were not statistically significant (results not shown). 
RESULTS 
The means and standard deviations for the concomitants and plasma lipid, lipoprotein and 
apolipoprotein levels for females and males are given in Table 2. The females were significantly 
younger, shorter and weighed less than the males. The mean plasma lipid, lipoprotein and 
apolipoprotein levels were significantly different between females and males for all traits except 
Lp(a). HDL-C and apo A1 levels were higher in females than males while the rest of the plasma 
lipid, lipoprotein and apolipoprotein levels were lower. The variances for weight, apo B and 
1nVLDL-C were significantly smaller in females than males. The variances of total cholesterol, 
LDL-C and HDL-C were also heterogeneous at  a less stringent level of statistical significance 
( p  < 0.10). These results confirm that the distributions of the concomitants and plasma lipid, 
lipoprotein and apolipoprotein traits were different in females and males and therefore the 
cladistic analysis was carried out separately by gender. 
The maximum parsimony cladogram using only those haplotypes observed in haplotype 6 
Cladistic analysis of apo AI-CIII-AIV 217 
Table 2. Means and standard deviations (s.D.) for the concomitants and plasma lipid, 
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Fig. 2. Maximum parsimony cladogram of the apo AI-CIII-AIV haplotypes. The R F L P  sites are listed 
5’ to  3’ ( X m n I  (InslDel) ,  X m n  I ,  Tag I ,  Pst I ,  Sst I and Pvu 11) and 1 and 0 denote cut  and uncut (no 
insert and insert) respectively. The designated haplotype number, number of males and number of 
females are given in parentheses. The RFLP site that  changes between the haplotypes is given on each 
branch. 
homo- ( n  = 74) and heterozygotes (n  = 66) is given in Fig. 2. Each connection in the cladogram 
occurred between haplotypes differing for a single RFLP marker and defined a contrast 
between individuals heterozygous for haplotype 6 and individuals homozygous for haplotype 
6. With seven haplotypes there are 21 possible pairwise contrasts. By using the cladogram, six 
evolutionarily relevant contrasts were selected representing exactly the number of degrees of 
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Fig. 3. Results of the cladistic analysis on adjusted plasma lipid levels in females and males. The 
profiles give the differences in the adjusted plasma lipid, lipoprotein and apolipoprotein levels between 
H 6  heterozygotes and H6 homozygotes for those genotypes that had at least one statistically 
significant contrast. * Denotes marginally significant differences, 005 < p < 010, and * denotes 
significant differences, p < 005. 
freedom when there are seven haplotypes. Thus, the mean values estimated for each of the six 
different types of heterozygotes carrying haplotype 6 were compared with the mean of those 
homozygous for haplotype 6. 
Before testing these contrasts, the traits were adjusted separately in females and males for 
variability in age, height, and weight to the third power, smoking and, in females, hormone use. 
The means and standard deviations for the concomitants and the adjusted plasma lipid, 
lipoprotein and apolipoprotein levels by gender are given for each genotype in Appendix I. The 
one-way analysis of variance and single degree of freedom contrasts are presented in Appendix 
11. The profile of mean differences for those haplotypes, in genotypes with haplotype 6, that had 
at  least one statistically significant difference in adjusted plasma lipid, lipoprotein or 
apolipoprotein levels relative to haplotype 6 homozygotes are depicted in Fig. 3. 
Using the cladogram to define a priori tests, there were statistically significant contrasts 
between specific genotypes. Haplotypes 1 ,  7 and 10, when in genotypes with haplotype 6, were 
associated with significant differences in adjusted levels of a t  least one plasma lipid, lipoprotein 
or apolipoprotein trait in each gender when contrasted with haplotype 6 homozygotes. As 
depicted in Fig. 3, the 1/6 genotype was significantly different from 6/6 homozygotes in the 
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level of adjusted HDL-C levels in females; the 1/6 heterozygotes had average HDL-C levels 
9.87 mg/dl higher than those observed in 6/6 homozygotes ( p  < 002) .  Also, the females with 
the 7/6 genotype had average adjusted apo A1 levels 17*96mg/dl lower than the 6/6 
homozygotes and this difference was marginally significant ( p  < 0.07). In males, haplotypes 1 ,  
7 and 10, when in genotypes with haplotype 6, were associated with significantly higher 
adjusted apo B, LDL-C and total cholesterol levels relative to haplotype 6 homozygotes and 
these differences are also depicted in Fig. 3. Males with the 10/6 genotype had average adjusted 
lipid, lipoprotein and apolipoprotein levels higher than 6/6 homozygotes by 37.93 mg/dl for 
total cholesterol levels ( p  < 0.03), 35-77 mg/dl for LDL-C levels ( p  < 0.01), and 36.72 mg/dl for 
apo B levels ( p  < 0.02). The total cholesterol, LDL-C and apo B contrasts between males with 
the 7/6 and 6/6 genotypes were marginally significant; males with the 7/6 genotype had 
22-79 mg/dl higher average adjusted total cholesterol levels ( p  < O l O ) ,  22-36 mg/dl higher 
average adjusted LDL-C levels ( p  < 0.06) and 23-84 mg/dl higher average adjusted apo B levels 
( p  < 0.06) than 6/6 homozygotes. The average adjusted LDL-C and apo B levels in 1/6 males 
were also marginally higher than those in 6/6 males, by 16.94 mg/dl ( p  < 0.08) and 18.07 mg/dl 
( p  < 007)  respectively. Because certain plasma lipid, lipoprotein and apolipoprotein levels are 
positively correlated, for example total cholesterol, LDL-C and apo B, it was not unexpected 
that they were similarly associated with haplotype variation. Thus, using only those 
individuals for whom haplotypes could be determined unambiguously and who carried at  least 
one copy of haplotype 6, haplotypes with gender specific effects on correlated lipid, lipoprotein 
and apolipoprotein levels were identified. 
DISCUSSION 
The analysis reported here is part of an ongoing study of a sample of healthy French 
Canadians (Haviland et al. 1991 ; Xhignesse et al. 1991 ; Zerba et al. 1991 ; Kessling et al. 1992). 
In a previous study, Kessling et al. (1992) established that the apo AI-CIII-AIV gene region 
should be considered as a contributor to the genetic architecture of lipid, lipoprotein and 
apolipoprotein traits, rather than just a candidate gene region. In  the present study, using a 
subset of the sample, the aim was to identify haplotypes hypothesized to differ for functional 
DNA sequence variations within the apo AI-CIII-AIV gene cluster that influence variation in 
plasma lipid, lipoprotein and apolipoprotein traits. The majority of individuals in this sample 
carried at  least one copy of a specific haplotype, designated haplotype 6. This haplotype 
frequency structure made i t  possible to carry out a haploid cladistic analysis to address the 
question : does variation in the other haplotype, carried by haplotype 6 heterozygotes, associate 
with variation in plasma lipid, lipoprotein and apolipoprotein traits. 
The cladogram estimated using the haplotypes present in this sample was consistent with 
many of the hypotheses from coalescent theory concerning the evolution of a gene region in a 
species (Crandall & Templeton, 1993). For example, coalescent theory suggests that interior 
haplotypes (those with more than one connection to  other haplotypes) should be more frequent 
than tip haplotypes. This is supported by the estimated cladogram for the apo AI-CIII-AIV 
region in which the most frequent haplotype, haplotype 6, was interior and the other 
haplotypes were all tips. Also, coalescent theory suggests that the most frequent haplotype 
should have the most connections. Again, the apo AI-CIII-AIV cladogram supports this 
hypothesis because haplotype 6, the most frequent haplotype, was connected to six other 
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haplotypes while all the other haplotypes were connected to only one. Thus, haplotype 6 is most 
likely the oldest haplotype and the other haplotypes descendants of it. 
The traditional analysis, using the one-way analysis of variance, did not detect an association 
between haplotype variation and adjusted plasma lipid trait variation in this sample. Rut, by 
using the estimated cladogram to define an a priori hypothesis testing scheme, the average 
adjusted plasma lipid, lipoprotein and apolipoprotein levels of three heterozygote classes, 1 /6, 
7/6 and 10/6, were found to differ from those of the 6/6 homozygotes. In females, haplotypes 
1 and 7 were associated with variation in the adjusted levels of HDL-C and apo AI, although 
1/6 females had on average high HDL-C levels while 7/6 females had on average low apo A1 
levels, as compared to 6/6 homozygotes. In males, haplotypes 1 ,  7 and 10, when in genotypes 
with haplotype 6, associated with elevated average adjusted total cholesterol, LDL-C and apo 
H levels as compared to 6/6 homozygotes. This study cannot distinguish between the 
possibilities that female and male inferences differed because different functional interindividual 
DNA sequence variations were acting in the genders, because the same functional 
interindividual DNA sequence variations had differing effects in the genders, or because of type 
I sampling errors. Assuming that the latter is not the case, it is unlikely that the interindividual 
DNA sequence variations acting in females and males were different because two different 
functional interindividual DNA sequence variations would have to be associated with the three 
haplotypes, each acting in only one gender. Rather, we hypothesize that the same functional 
interindividual DNA sequence variations were acting, but the effects of these variations differed 
between the genders and hence were context dependent. 
It was not unexpected that the plasma lipid, lipoprotein and apolipoprotein traits associated 
with haplotype variation were different in females and males. The distributions of plasma lipid, 
lipoprotein and apolipoprotein traits in females and males have been shown to be quite different, 
suggesting that the underlying biology may also be different (e.g. Table 2, National Center for 
Health Statistics et al. 1986; Reilly et al. 1990; Kottke et al. 1991 ; The Bezafibrate Infarction 
Prevention (BIP) Study Group Israel, 1992). Also, there is a growing body of literature 
demonstrating that genotype effects on measures of lipid metabolism are gender specific (e.g. 
Hanis et al. 1991; Kaprio et al. 1991; Reilly et al. 1991, 1992, 1994; Xhignesse et al. 1991; 
Kessling et al. 1992; Hegele et al. 1994). These gender differences may be due, in part, to the 
association between variation in sex hormone levels and variation in lipid, lipoprotein and 
apolipoprotein trait levels (Kim & Kalkhoff, 1979; Gorbach et al. 1989) and/or variation in sex 
hormone levels leading to differential regulation of the genes involved in lipid metabolism (e.g. 
Archer et al. 1986). Thus, it is reasonable to hypothesize that the same functional interindividual 
DKA sequence variations in the apo AI-CIII-AIV gene cluster were acting in females and males 
in the study reported here but interactions with different modifying factors associated with 
gender resulted in different penetrance functions. 
Many association studies, using single RFLP loci in the apo AI-CIII-AIV gene cluster a8 the 
measure of genetic variation, have found associations with variation in plasma lipid, lipoprotein 
and apolipoprotein levels (reviewed by Humphries et al. 1987; Humphries, 1988; Lusis, 1988; 
Boerwinkle & Hixson, 1990). Most studies, of males only or males and females analysed 
separately, have found associations between variation in the apo AI-CIII-AIV gene cluster and 
variation in HDL-C and apo A1 levels (Kessling et al. 1988b; Paulweber et al. 1988; Wile et al. 
1989; Jeenah et al. 1990; Kessling et al. 1992). However, the exact RFLP in association with 
Cladistic analysis of apo AI-CIII-AIV 22 1 
the differing plasma lipid levels was not the same in all studies (Haviland et al. 1991). I t  is 
generally hypothesized that the interindividual DNA sequence variation(s) responsible for the 
association with plasma apo A1 and HDL-C levels is located in the apo A1 gene. However, until 
the functional interindividual DNA sequence variation(s) have been identified, the hypothesis 
that the responsible sequences are located in or around the apo CIII and AIV genes, or in 
regulatory sequences within or to  either side of the cluster, must also be considered. 
The association between haplotype variation in the apo AI-CIII-AIV gene cluster with 
variation in HDL-C and apo A1 levels was only observed in females in this cladistic analysis; 
in males the association was found with variation in apo B, LDL-C and total cholesterol levels. 
Only two previous analyses found associations between apo AI-CIII-AIV genetic variability 
and variation in LDL-C levels in males (Kessling et al. 1988a; Aalto-Setala et al. 1991). The 
association of variation in the apo AI-CIII-AIV gene cluster with variation in many different 
lipid, lipoprotein and apolipoprotein traits is expected given that lipid metabolism is a complex 
coherent system of interacting agents (Sing &, Reilly, 1993). 
Within males, the effect of the three haplotypes identified by the cladistic analysis were 
similar, but it is unclear whether the functional interindividual DNA sequence variation(s) 
detected were the same in all three haplotypes or different. It is tempting to hypothesize that 
the three haplotypes had a common ancestor carrying ‘the ’ functional interindividual DNA 
sequence variation(s) and the three haplotypes diverged from it,  a t  other sites, over time. This 
hypothesis is similar to Weiss’s characterization of the evolution of functional alleles as a 
fractal process (Weiss, 1993). Under this characterization, a new mutation will evolve into 
a clade of descendent alleles, each clonal for the mutation. The alleles in this clade continue to 
evolve as other mutations accumulate. In  this way, evolution generates a fractal structure of 
alleles and allele effects. I n  contrast to this hypothesis of a common ancestral DNA sequence 
variation, i t  may be that the functional interindividual DNA sequence variations in the 
haplotypes arose independently and probably at different sites. Of course, the answer will not 
be definitive until the functional DNA sequence variations have been identified. 
A cladistic analysis can be used to generate hypotheses about which haplotypes should be 
compared to have the greatest chance of finding candidate DNA sequences responsible for the 
observed phenotypic effects. In the apo AI-CIII-AIV region, this analysis suggests that 
haplotypes 1,  7 and 10 should be compared to haplotype 6 because they are hypothesized to 
differ for one or more functional interindividual DNA sequence variation(s) but are similar for 
a large part of the gene region. A cladistic analysis can also be used to generate hypotheses 
about which haplotypes are unlikely to differ for functional DNA sequence variations. From 
this analysis there is no evidence to suggest that  haplotypes 3, 5 and 8 differ from haplotype 
6 a t  a functional sequence variation and thus, it is unlikely that the DNA sequence variations 
that differentiate them have a functional effect on plasma lipid, lipoprotein or apolipoprotein 
levels. 
An iterative cladistic approach is presently being developed aimed at identifying functional 
DNA sequence variations. This approach expands on the use of the cladistic approach to 
generate hypotheses about which haplotypes are likely or unlikely to differ for functional DNA 
sequence variations, and subsequently which DNA sequence variations are likely or unlikely to 
be functional, by applying the cladistic approach in an iterative fashion (Haviland et al. in 
preparation). 
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In summary, three haplotypes in the apo AI-CIII-AIV gene cluster were identified that, when 
in genotypes with haplotype 6, were associated with significant differences in adjusted plasma 
lipid, lipoprotein and apolipoprotein levels relative to haplotype 6 homozygotes. In females, the 
haplotypes associated with variation in adjusted levels of HDL-C and apo AI,  while in males 
they were associated with variation in adjusted levels of total cholesterol, LDL-C and apo B. 
Thus, the study presented here suggests that interindividual DNA sequence variations in the 
apo AI-CIII-AIV gene region have pleiotropic effects on several measures of lipid metabolism 
and the nature of these effects is gender dependent. 
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APPENDIX I : MEANS AND STANDARD DEVIATIONS FOR CONCOMITANTS AND ADJUSTED PLASMA 
LIPID, LIPOPROTEIN AND APOLIPOPROTEIN TRAITS BY GENDER AND APO AI-CIII-AIV GENOTYPE 
Genotype 1/6 
Females ( n  = 10) Males ( n  = 10) 
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AlnTrig. (In mg/dl) 
AHDL-C (mg/dl) 
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AlnVLDL-C (In mg/dl) 
AlnTrig. (In mg/dl) 
AHDL-C (mg/dl) 
AApoAI (mg/dl) 
AlnLp(a) (In mg/dl) 
Genotype 3/6 
Females (n = 1) Males (n = 4) 
Mean S.D. Mean S.D. 
32.00 - 39.25 7.68 
1.68 - 1.74 006 


















Females (n = 2) Male8 (n  = 7) 
Mean S.D. Mean S.D. 
3150 636 3486 601 
1.68 008 1.71 006 


























Females (n = 25) Males (n = 49) 
Mean S.D. Mean S.D. 
35.76 642 3951 812 
1.62 005 1.72 006 








































AlnVLDL-C (In mg/dl) 
AlnTrig. (In mg/dl) 
AHDL-C (rng/dl) 
AApoAI (mg/dl) 
AlnLp(a) (In mg/dl) 
APPENDIX I. (Cod.)  
Genotype 7/6 
Females (n = 6) Males (n = 6) 
Mean S.D. Mean S.D. 
37.17 512  35.83 952 
1.62 004  1.71 004  




2.67 024  
403  021  












Females (n = 4) Males (n = 10) 







AlnVLDL-C (In mg/dl) 
AlnTrig. (In mg/dl) 
AHDL-C (mg/dl) 
AApoAI (mg/dl) 
AlnLp(a) (In mg/dl) 
38.50 656  43.50 7.29 
1.59 0 0 5  1.74 006  
57.73 402 72.82 11.06 
17968 2446 187.78 12.64 
113.67 2835 124.27 17.90 
10098 2430 120.41 22.01 
2.96 032  3.12 026  
4.33 0 2 6  4.55 031  
46.32 983  39.28 904  
133.00 25.81 121.57 14.46 
1-88 1.40 1.56 1.44 
Genotype 10/6 
Females (n = 2) Males (n = 4) 
Mean S.D. Mean S.D. 
Age (years) 





AlnVLDL-C (In mg/dl) 
AlnTrig. (In mg/dl) 
AHDL-C (mg/dl) 
AApoAI (mg/dl) 


















0 6 5  
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APPENDIX I1 SUMMARY OF CLADISTIC ANALYSIS OF APO AI-CIII-AIV GENE REGION 
T-Chol. in females 




616 v. 116 
616 v. 316 
616 v. 516 
616 v. 716 
616 v. 816 




















7 43 2.0 
1 0 0  
43 0 1  
23785 63.0 
L D I X  in femaleR 






















616 v. 116 
616 v. 316 
616 v. 516 
616 v. 716 
616 v. 816 




















62 0 2  
0 0 0  
3 0 0  
20354 667 
Apo B in females 






















616 v. 116 
616 v. 316 
616 v. 516 
616 v. 716 
616 v. 816 




















0 2  0.12 
0 1  0.06 
- 
606 ~ 
In VLDL-C in females 














616 v. 116 
616 v. 316 
616 v. 516 
616 v. 716 
616 v. 816 
616 v. 1016 
Unexplained 
- - 49 6.83 100.0 
11 0.84 12.3 045 0.92 
6 055 8.1 054 0.77 
1 013 1% 076 039 
1 003 0 4  0.18 067 
1 0.11 1.6 0.65 043 
1 0.11 1.6 0.65 043 
1 0.07 1.0 0.41 053 
1 0.06 0.9 0.35 056 
32 5.44 79.6 ~ - 
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APPENDIX I1 (COnt.) 
In Trig. in females 




616 v .  116 
616 v .  316 
616 v .  516 
616 v. 716 
616 v .  816 







616 v. 316 
616 u. 516 
616 v .  716 
616 u.  816 


























0.5 1 8.0 
0.0 1 0 2  
0.25 3.9 
0 0  1 0.2 
0.16 2.5 
0.05 0 8  
0.02 0 3  
3.06 48.1 






5 0 1  





Apo A1 in females 














































Total 49 21487 100.0 - - 
Concomitants 11 3174 14% 0.65 0.77 
Genotypes 
616 v .  116 
616 v. 316 
616 v. 516 
616 v .  716 
616 t i .  816 






616 ti. 116 
616 v. 316 
616 v. 516 
616 v. 716 
616 v. 816 



















19.1 1.54 020 
1.3 0.63 043 
0.2 012 073 
5.5 2.65 011 
7.3 3.51 007 
0.3 0.16 069 
2.2 1.07 0.31 
66.1 - - 
In Lp(a)  in females 













6.1 9 8.4 
0.15 0.2 
0.4 1 1 .0 
0.03 0 0  
1.35 1.8 
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APPENDIX I1 (Cod.)  
Total Chol. in males 




616 u. 116 
616 v .  316 
616 v .  516 
616 u.  716 
616 u.  816 
















160 0 1  
596 0 5  
2778 2.5 
16 0 0  




















LDL-C in males 




616 u. 116 
616 v. 316 
616 u. 516 
616 u. 716 
616 v. 816 

















893 1 .0 
2671 3.1 
102 0.1 


















Apo B in males 




616 u. 116 
616 v .  316 
616 u. 516 
616 u. 716 
616 u. 816 












































616 u. 116 
616 v. 316 
616 71. 516 
616 u. 716 
616 u.  816 




























0 1  
0.5 




















Cladistic analysis of apo AI-CIII-AIV 23 1 
APPENDIX I1 ( C o d . )  
In Trig. in males 
Source D.F.  ss (Yo) ss 
Total 89 21.88 100.0 
Concomitants 10 3.40 15.5 
Genotypes 6 044 2.0 
616 v. 116 1 002 0 1  
616 v. 316 1 002 0 1  
616 v. 516 1 002 0 1  
616 v .  716 1 004 0 2  
616 v. 816 1 007 0 3  
616 v. 1016 1 031 1.4 










HDL-C in males 
Source D.F.  9 s  (Yo) SS F p-value 
Total 89 7138 1000 
Concomitants 10 1158 162 1.44 0.18 
Genotypes 6 107 1.5 022 0.97 
616 v .  116 1 2 0 0  002 089 
616 v. 316 1 2 0 0  002 089 
616 v. 716 1 54 0 7  067 042 
616 v. 816 1 29 0 4  036 055 
616 v. 1016 1 40 0% 0.50 048 
- - 
616 v .  516 1 0 0 0  000 099 
Unexplained 73 5873 82.3 - - 
Apo A1 in males 




616, .  116 
616 v. 316 
616 v. 516 
616 v .  716 
616 v .  816 

















616 v .  116 
616 v .  316 
616 v .  516 
616 v .  716 
616 v. 816 













7 806 199 



















137.76 7 7 5  
- 
1.94 
0.85 
050 
1-77 
1.16 
0.77 
0.90 
0.02 
F 
- 
005 
054 
048 
019 
029 
038 
0.35 
0.89 
p-value 
- 
1.32 
1.32 
021 
3.78 
0.06 
1.98 
1.12 
004 
0.24 
0.26 
0.65 
0.06 
0.8 1 
0.16 
0.29 
0.84 
